One pharma company is taking an unconventional approach to heart disease awareness: launching a drone show to educate people ...

NewAmsterdam Pharma Company N.V.’s NAMS share price has dipped by 10.21%, which has investors questioning if this is right time to buy.

Inhibition of cholesteryl ester transfer protein (CETP) increases HDL-cholesterol levels and decreases LDL-cholesterol levels; therefore, CETP inhibition represents a potential therapeutic approach.

The mechanism that underlies the increase in HDL-cholesterol levels during statin therapy is poorly understood; proposed mechanisms include the reduction of cholesteryl ester transfer protein ...